首页> 外文期刊>Cancer biology & therapy >Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract
【24h】

Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract

机译:类固醇激素受体在上尿路尿路上皮癌中的表达及其预后意义

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the expression status of steroid hormone receptors in upper urinary tract urothelial carcinoma (UUTUC), we immunohistochemically stained for androgen receptor (AR), estrogen receptor-alpha (ER alpha), ER beta, glucocorticoid receptor (GR), and progesterone receptor (PR) in 99 UUTUC specimens and paired nonneoplastic urothelial tissues. AR/ER alpha/ER beta/GR/PR was positive in 20%/18%/62%/63%/16% of tumors, which was significantly lower (except PR) than in benign urothelial tissues [57% (P < 0.001)/40% (P = 0.001)/85% (P = 0.001)/84% (P = 0.002)/13% (P = 0.489)]. There were no significant associations between each receptor expression pattern and histopathological characteristic of the tumors including tumor grade/stage. Kaplan-Meier and log-rank tests revealed no significant prognostic value of each receptor expression in these 99 patients. However, patients with UUTUC positive for either ER alpha or PR had a significantly higher risk of disease-specific mortality (P = 0.025), compared with those with UUTUC negative for both. PR positivity alone in pT3 or pT4 tumors was also strongly associated with the risk of disease-specific mortality (P = 0.040). Multivariate analysis further identified the expression of ER alpha and/or PR as a strong predictor for disease-specific mortality in the entire cohort of the patients (hazard ratio, 2.434; P = 0.037). Thus, in accordance with previous observations in bladder specimens, significant decreases in the expression of AR/ER alpha/ER beta/GR in UUTUC, compared with that in non-neoplastic urothelium, were observed. Meanwhile, the negativity of both ERa and PR in UUTUC as well as the negativity of PR alone in deeply invasive tumor was suggested to serve as a prognosticator.
机译:为了评估类固醇激素受体在上尿路尿路上皮癌(UUTUC)中的表达状态,我们对雄激素受体(AR),雌激素受体α(ER alpha),ERβ,糖皮质激素受体(GR)和孕激素受体进行了免疫组织化学染色(PR)在99个UUTUC标本和成对的非肿瘤性尿路上皮组织中。 AR / ER alpha / ER beta / GR / PR在20%/ 18%/ 62%/ 63%/ 16%的肿瘤中呈阳性,这比良性尿道上皮组织显着降低(PR除外)[57%(P < 0.001)/ 40%(P = 0.001)/ 85%(P = 0.001)/ 84%(P = 0.002)/ 13%(P = 0.489)]。每种受体的表达方式与肿瘤的组织病理学特征(包括肿瘤的分级/阶段)之间没有显着的关联。 Kaplan-Meier和对数秩检验显示,在这99例患者中,每种受体的表达均无明显预后价值。然而,与UUTUC阴性的患者相比,ERUT或PR的UUTUC阳性的患者具有更高的疾病特异性死亡率风险(P = 0.025)。 pT3或pT4肿瘤中仅PR阳性也与疾病特异性死亡风险密切相关(P = 0.040)。多变量分析进一步确定了ERα和/或PR的表达是整个患者队列中疾病特异性死亡率的有力预测指标(危险比,2.434; P = 0.037)。因此,根据先前在膀胱标本中的观察,与非肿瘤性尿路上皮相比,在UUTUC中观察到AR / ER alpha / ER beta / GR的表达显着下降。同时,建议UUTUC中ERα和PR的阴性以及深浸润性肿瘤中单独PR的阴性可作为预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号